Skip to content
Kansas City, MO - IMF Myeloma Community Workshop 2026 Evaluation
1.
I am a (Choose all that apply)
Patient
Care Partner of a Patient
Family Member of a Patient
Support Group Leader
Health Care Provider
Industry Partner
Other (please specify)
2.
Which of the following best applies to you?
This is my first IMF Educational Program
I attend IMF Educational Programs on a regular basis
I have attended IMF Educational Programs previously, but not in the last year
3.
How long ago were you or the person you care for diagnosed? (choose one)
Less than 3 months
Between 3 months and 1 year
Between 1 and 5 years
Between 5 and 10 years
Between 10 and 15 years
15 or more years
Not applicable
Please only evaluate the presentations that you attended.
4.
Please rate the value of each presentation.
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Understanding Myeloma Basics
- Tanya Wildes, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
VIDEO - Closing the Gap: Health Disparities in Myeloma
- Joseph Mikhael, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Advancing Treatment Options Through Clinical Trials
- Rakesh Gaur, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Q & A with Panel
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Breakout Session - Newly Diagnosed Myeloma: Getting Started with Treatment
- Rakesh Gaur, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Breakout Session - Relapsed Myeloma: Continuing Treatment
- Tanya Wildes, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Myeloma: Putting the Pieces of the Puzzle Together
- Teresa Miceli, BSN, RN, OCN
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Living the Myeloma Life: Local Patient
- Jim Weber
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
The Unseen Impact of Myeloma: Taking Care of your Emotional Health
- Jennifer Wieworka, DNP, RN, OCN
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Q & A with Panel
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
5.
This presentation increased my understanding of the topic.
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Understanding Myeloma Basics
- Tanya Wildes, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
VIDEO - Closing the Gap: Health Disparities in Myeloma
- Joseph Mikhael, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Advancing Treatment Options Through Clinical Trials
- Rakesh Gaur, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Q & A with Panel
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Breakout Session - Newly Diagnosed Myeloma: Getting Started with Treatment
- Rakesh Gaur, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Breakout Session - Relapsed Myeloma: Continuing Treatment
- Tanya Wildes, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Myeloma: Putting the Pieces of the Puzzle Together
- Teresa Miceli, BSN, RN, OCN
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Living the Myeloma Life: Local Patient
- Jim Weber
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
The Unseen Impact of Myeloma: Taking Care of your Emotional Health
- Jennifer Wieworka, DNP, RN, OCN
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Q & A with Panel
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
6.
After attending this program, rate your overall perception of clinical trials.
1 - Extremely Negative
2 - Negative
3 - Neutral
4 - Positive
5 - Extremely Positive
1 - Extremely Negative
2 - Negative
3 - Neutral
4 - Positive
5 - Extremely Positive
7.
After attending this program, how open would you be to considering a clinical trial if recommended by your doctor?
1 - Not at all Open
2 - Slightly Open
3 - Moderately Open
4 - Very Open
5 - Extremely Open
1 - Not at all Open
2 - Slightly Open
3 - Moderately Open
4 - Very Open
5 - Extremely Open
8.
I plan to share what I learned from this program with: (select all that apply)
My healthcare team
My care partner
My family or friends
My support group
On social media
I do not plan to share
Other (please specify)
9.
Please share any additional feedback